PRACTICE ALERT PODCAST

ACP issues 4 statements on T2DM treatment targets

J Fam Pract. 2018 May;67(5):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

In March 2018, The American College of Physicians issued 4 guidance statements on the use of hemoglobin A1c targets for nonpregnant adults with type 2 diabetes. In this audiocast, Dr. Doug Campos-Outcalt describes these statements and the ways that they differ—often significantly—from other guidelines.

 

Resource

Qaseem A, Wilt TJ, Kansagara D, et al, for the Clinical Guidelines Committee of the American College of Physicians. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Int Med. 2018; Mar 6. doi: 10.7326/M17-0939. [Epub ahead of print].

Recommended Reading

FDA approves marketing for retinal imaging device that uses artificial intelligence
MDedge Family Medicine
VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
MDedge Family Medicine
‘Fast food swamps’ linked to type 1 diabetes
MDedge Family Medicine
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Family Medicine
Targeting obesity could slow brain aging in psychosis
MDedge Family Medicine
Nitric oxide–generating dressing holds promise for diabetic foot ulcers
MDedge Family Medicine
Artificial pancreas treatment improves glycemic control in T1DM: Meta-analysis
MDedge Family Medicine
MDedge Daily News: Physician burnout needs more than yoga
MDedge Family Medicine
Hormone therapy raises diabetes risk in breast cancer survivors
MDedge Family Medicine
Metabolic syndrome scoring system predicts CVD in type 2 diabetes
MDedge Family Medicine